Compounds as modulators of mutant cftr proteins and their use in the treatment of diseases associated with cftr protein disorders
A protein disorder, F508-CFTR technology, applied in the field of new protein regulators, can solve problems such as exocrine pancreatic duct obstruction
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0100] Materials and methods
[0101] Antibody
[0102] The following antibodies were used: MAB25031 (clone 24-1, R&D systems, USA) and MM13-4 (Upstate), monoclonal antibodies (mAb) for CFTR detection; fluorescent secondary antibodies Alexa 594 and 488 from Molecular Probes (CergyPontoise, France )Buy.
[0103] cell culture
[0104] Stably transfected HeLa cells (HeLa cells only contain the pTracer plasmid as a control (pTracer), or express WT-CFTR (spTCF-WT), ΔF508-CFTR (spTCF-F508del)) were prepared by Pascale Fanen (Inserm U.468, Créteil , France) and cultured as described elsewhere (16). Briefly, HeLa cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% heat-inactivated FCS, 100 U / ml penicillin, 100 μg / ml streptomycin and 250 μg / ml zeocin antibiotics. at 37°C in 5% CO 2 cultured in a humidified incubator. Expression of WT-CFTR and ΔF508-CFTR in these cells was verified by immunoprecipitation and immunocytochemistry throughout th...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com